634 related articles for article (PubMed ID: 18245227)
1. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
3. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
4. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
Suh JH; Shong M; Choi HS; Lee K
Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
[TBL] [Abstract][Full Text] [Related]
5. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1.
Hong CY; Gong EY; Kim K; Suh JH; Ko HM; Lee HJ; Choi HS; Lee K
Mol Endocrinol; 2005 Sep; 19(9):2245-57. PubMed ID: 15919722
[TBL] [Abstract][Full Text] [Related]
8. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
9. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
10. Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism.
Choi SM; Cho HJ; Cho H; Kim KH; Kim JB; Park H
Nucleic Acids Res; 2008 Nov; 36(20):6372-85. PubMed ID: 18838394
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K
Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J
Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255
[TBL] [Abstract][Full Text] [Related]
14. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs.
Dif N; Euthine V; Gonnet E; Laville M; Vidal H; Lefai E
Biochem J; 2006 Nov; 400(1):179-88. PubMed ID: 16831124
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase.
Jeong BC; Hong CY; Chattopadhyay S; Park JH; Gong EY; Kim HJ; Chun SY; Lee K
Mol Endocrinol; 2004 Jan; 18(1):13-25. PubMed ID: 14576337
[TBL] [Abstract][Full Text] [Related]
17. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
Wang LG; Ossowski L; Ferrari AC
Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193
[TBL] [Abstract][Full Text] [Related]
19. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes.
Im SS; Kwon SK; Kang SY; Kim TH; Kim HI; Hur MW; Kim KS; Ahn YH
Biochem J; 2006 Oct; 399(1):131-9. PubMed ID: 16787385
[TBL] [Abstract][Full Text] [Related]
20. In vivo promoter analysis on refeeding response of hepatic sterol regulatory element-binding protein-1c expression.
Takeuchi Y; Yahagi N; Nakagawa Y; Matsuzaka T; Shimizu R; Sekiya M; Iizuka Y; Ohashi K; Gotoda T; Yamamoto M; Nagai R; Kadowaki T; Yamada N; Osuga J; Shimano H
Biochem Biophys Res Commun; 2007 Nov; 363(2):329-35. PubMed ID: 17880923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]